Market Cap : 279.31 B | Enterprise Value : 289.29 B | PE Ratio : 9.73 | PB Ratio : 3.38 |
---|
NYSE:PFE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:PFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pfizer's Enterprise Value is $289,287 Mil. Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $33,772 Mil. Therefore, Pfizer's EV-to-EBIT for today is 8.57.
The historical rank and industry rank for Pfizer's EV-to-EBIT or its related term are showing as below:
During the past 13 years, the highest EV-to-EBIT of Pfizer was 3034.67. The lowest was 8.60. And the median was 16.98.
PFE's EV-to-EBIT is ranked better thanJoel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Pfizer's Enterprise Value for the quarter that ended in Mar. 2022 was $300,862 Mil. Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $33,772 Mil. Pfizer's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was 11.23%.
The historical data trend for Pfizer's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Pfizer's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Pfizer's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Pfizer's EV-to-EBIT falls into.
Pfizer's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 289287.105 | / | 33772 | |
= | 8.57 |
Pfizer's current Enterprise Value is $289,287 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $33,772 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Pfizer's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Mar. 2022 ) | = | EBIT | / | Enterprise Value (Q: Mar. 2022 ) |
= | 33772 | / | 300862.07 | |
= | 11.23 % |
Pfizer's Enterprise Value for the quarter that ended in Mar. 2022 was $300,862 Mil.
Pfizer's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $33,772 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Pfizer's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Denton David M | officer: Chief Financial Officer & EVP | 1000 LOWE'S BOULEVARD MOORESVILLE NC 28117 |
Pao William | officer: Executive Vice President | C/O CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Mcdermott Michael | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET 235 EAST 42ND STREET NY 10017 |
Malik Aamir | officer: Executive Vice President | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Carapezzi William R Jr | officer: Executive Vice President | 600 MOUNTAIN AVENUE MURRAY HILL NJ 07921 |
Sahni Payal | officer: Executive Vice President | ATTN: PFIZER CORP. SECRETARY 235 EAST 42ND ST. NEW YORK NY 10017 |
Desmond-hellmann Susan | director | 513 PARNASSUS AVENUE S126 SAN FRANCISCO CA 94143 |
Hockfield Susan | director | GENERAL ELECTRIC COMPANY 41 FARNSWORTH STREET BOSTON MA 02210 |
Damico Jennifer B. | officer: SVP & Controller | C/O PFIZER INC. CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017 |
Quincey James | director | THE COCA-COLA COMPANY ONE COCA-COLA PLAZA ATLANTA GA 30313 |
Gottlieb Scott | director | MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142 |
Fonseca Lidia | officer: Executive Vice President | 358 SOUTH MAIN STREET BURLINGTON NC 27215 |
Goettler Michael | officer: Group President | 1000 MYLAN BOULEVARD CANONSBURG PA 15317 |
Rogers Dawn | officer: Executive Vice President | 235 EAST 42ND STREET NEW YORK NY 10017 |
Littman Dan R. | director | ATTN: CORPORATE SECRETARY PFIZER INC. 235 E. 42ND ST NEW YORK NY 10017 |
From GuruFocus
Other Sources
By Zacks 2022-03-29
By Fool 2022-04-05
By Zacks 2022-03-25
By Zacks 2022-04-01
By Zacks 2022-03-25
By Zacks 2022-03-23
By Zacks 2022-03-28
By Zacks 2022-03-30
By tipranks.com 2022-04-01
By Zacks 2022-03-23
By Zacks 2022-03-22